Griebenow R, Müller R, Steffen H M, Burger K J, Welzel D
Department of Internal Medicine II, University of Cologne, Germany.
Am J Hypertens. 1993 Mar;6(3 Pt 2):92S-94S. doi: 10.1093/ajh/6.3.92s.
The comparative efficacy of the calcium antagonists isradipine and nifedipine in reducing left ventricular peak systolic wall tension was assessed in 25 patients with essential hypertension (20 men, 5 women; mean age: 49 years). After 2 weeks of treatment with either isradipine (2.5 mg twice daily) or slow-release nifedipine (20 mg twice daily), blood pressure was similarly reduced in both groups of patients whereas the thickness of the interventricular septum and left ventricular free wall did not change. Echocardiographic end-diastolic volume of the left ventricle showed no change whereas end-systolic volume significantly decreased with isradipine, but not with nifedipine retard. This led to a significant reduction in peak systolic wall tension in the isradipine group, but not in the nifedipine group. In conclusion, antihypertensive treatment with isradipine produces a reduction in peak systolic wall tension which is not seen with nifedipine, probably because of its negative inotropic effect.
在25例原发性高血压患者(20例男性,5例女性;平均年龄:49岁)中评估了钙拮抗剂伊拉地平与硝苯地平在降低左心室收缩期峰值壁张力方面的比较疗效。在用伊拉地平(每日两次,每次2.5毫克)或缓释硝苯地平(每日两次,每次20毫克)治疗2周后,两组患者的血压均有相似程度的降低,而室间隔厚度和左心室游离壁厚度未发生变化。左心室超声心动图舒张末期容积无变化,而伊拉地平治疗后收缩末期容积显著降低,缓释硝苯地平治疗则未出现此情况。这导致伊拉地平组的收缩期峰值壁张力显著降低,而硝苯地平组未降低。总之,伊拉地平降压治疗可降低收缩期峰值壁张力,而硝苯地平则无此作用,这可能是由于伊拉地平具有负性肌力作用。